Valensa, Mercola Health Enter into Supply Agreement
October 21, 2010
ORLANDO, Fla. and HOFFMAN ESTATES, Ill.Valensa International and Mercola Health Resources LLC entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES joint health formulation. With one tablet a day, Flex Pro ES is designed to provide both near- and long-term support of joint health featuring four proven joint health ingredientsZanthin® Natural Astaxanthin, BiovaFlex Water-Soluble Egg Shell Membrane, boswellia and hyaluronic acid (HA). The formula specifically avoids the use of chondroitin and glucosamine/MSM, ingredients that can lead to unnecessary salt burden and swallowing difficulty.
Flex Pro ES is a multi-ingredient formulation combining boswellia with the anti-inflammatory and antioxidant properties of astaxanthin and a specialized form of HA, along with the elastin, elastin precursors and collagen, found in BiovaFlex for increased flexibility and long-term joint health.
You May Also Like